ID

22049

Description

Study part: Prior treatment for breast cancer (Adjuvant setting). A phase III multinational, randomized, single-blind study of recombinant humanized anti-p185HER2 monoclonal antibody (rhuMAb HER2) in patients with HER2/neu overexpression who have not received prior cytotoxic chemotherapy for metastatic breast cancer. "Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche"

Mots-clés

  1. 16/05/2017 16/05/2017 -
  2. 15/03/2021 15/03/2021 - Dr. rer. medic Philipp Neuhaus
Détendeur de droits

Roche

Téléchargé le

16 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

PRIOR TREATMENT FOR BREAST CANCER (ADJUVANT SETTING) Roche H0650g Breast Cancer

PRIOR TREATMENT FOR BREAST CANCER (ADJUVANT SETTING)

REGIMEN 1
Description

REGIMEN 1

Alias
UMLS CUI-1
C0392920
PATIENT INT.
Description

Patient initial

Type de données

text

Alias
UMLS CUI [1]
C2986440
PATIENT NUMBER
Description

Patient id

Type de données

integer

Alias
UMLS CUI [1]
C2348585
CHEMOTHERAPY?
Description

Chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
START DATE OF FIRST AGENT
Description

therapy start date

Type de données

date

Alias
UMLS CUI [1]
C1531783
STOP DATE OF LAST AGENT
Description

therapy stop date

Type de données

date

Alias
UMLS CUI [1]
C1531784
AGENT(S)
Description

Pharmaceutical Preparations

Type de données

text

Alias
UMLS CUI [1]
C0013227
CUMULATIVE DOSE RC'D (Units)
Description

CUMULATIVE DOSE

Type de données

text

Alias
UMLS CUI [1]
C2986497
NUMBER OF CYCLES
Description

NUMBER OF CYCLES

Type de données

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C1302181
REGIMEN 2
Description

REGIMEN 2

Alias
UMLS CUI-1
C1276413
START DATE OF FIRST AGENT
Description

therapy start date

Type de données

date

Alias
UMLS CUI [1]
C1531783
STOP DATE OF LAST AGENT
Description

therapy stop date

Type de données

date

Alias
UMLS CUI [1]
C1531784
AGENT(S)
Description

Pharmaceutical Preparations

Type de données

text

Alias
UMLS CUI [1]
C0013227
CUMULATIVE DOSE RC'D (Units)
Description

CUMULATIVE DOSE

Type de données

text

Alias
UMLS CUI [1]
C2986497
NUMBER OF CYCLES
Description

NUMBER OF CYCLES

Type de données

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C1302181
ADJUVANT THERAPY
Description

ADJUVANT THERAPY

Alias
UMLS CUI-1
C0677850
WAS A HIGH-DOSE CONSOLIDATION THERAPY GIVEN?
Description

CONSOLIDATION THERAPY

Type de données

boolean

Alias
UMLS CUI [1]
C1511484
DID THE PATIENT RECEIVE A BONE MARROW OR STEM CELL- TRANSPLANT?
Description

Bone marrow transplantation; stem cell transplantation

Type de données

boolean

Alias
UMLS CUI [1]
C1504389
DID PATIENT PROGRESS WITHIN 12 MONTHS FOLLOWING THE ADJUVANT CHEMOTHERAPY?
Description

Disease progression

Type de données

boolean

Alias
UMLS CUI [1]
C0242656
WHAT WAS THE TOTAL DOSE OF DOXORUBICIN IN AN ADJUVANT SETTING?
Description

Total dose Doxorubicin

Type de données

float

Unités de mesure
  • mg/m^2
Alias
UMLS CUI [1,1]
C2986497
UMLS CUI [1,2]
C0013089
UMLS CUI [1,3]
C0014582
mg/m^2
WHAT WAS THE TOTAL DOSE OF EPIRUBICIN USED IN AN ADJUVANT SETTING?
Description

Total dose Epirubicin

Type de données

float

Unités de mesure
  • mg/m^2
Alias
UMLS CUI [1,1]
C2986497
UMLS CUI [1,2]
C0014582
mg/m^2

Similar models

PRIOR TREATMENT FOR BREAST CANCER (ADJUVANT SETTING)

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
REGIMEN 1
C0392920 (UMLS CUI-1)
Patient initial
Item
PATIENT INT.
text
C2986440 (UMLS CUI [1])
Patient id
Item
PATIENT NUMBER
integer
C2348585 (UMLS CUI [1])
Chemotherapy
Item
CHEMOTHERAPY?
boolean
C0392920 (UMLS CUI [1])
therapy start date
Item
START DATE OF FIRST AGENT
date
C1531783 (UMLS CUI [1])
therapy stop date
Item
STOP DATE OF LAST AGENT
date
C1531784 (UMLS CUI [1])
Pharmaceutical Preparations
Item
AGENT(S)
text
C0013227 (UMLS CUI [1])
CUMULATIVE DOSE
Item
CUMULATIVE DOSE RC'D (Units)
text
C2986497 (UMLS CUI [1])
NUMBER OF CYCLES
Item
NUMBER OF CYCLES
integer
C0449788 (UMLS CUI [1,1])
C1302181 (UMLS CUI [1,2])
Item Group
REGIMEN 2
C1276413 (UMLS CUI-1)
therapy start date
Item
START DATE OF FIRST AGENT
date
C1531783 (UMLS CUI [1])
therapy stop date
Item
STOP DATE OF LAST AGENT
date
C1531784 (UMLS CUI [1])
Pharmaceutical Preparations
Item
AGENT(S)
text
C0013227 (UMLS CUI [1])
CUMULATIVE DOSE
Item
CUMULATIVE DOSE RC'D (Units)
text
C2986497 (UMLS CUI [1])
NUMBER OF CYCLES
Item
NUMBER OF CYCLES
integer
C0449788 (UMLS CUI [1,1])
C1302181 (UMLS CUI [1,2])
Item Group
ADJUVANT THERAPY
C0677850 (UMLS CUI-1)
CONSOLIDATION THERAPY
Item
WAS A HIGH-DOSE CONSOLIDATION THERAPY GIVEN?
boolean
C1511484 (UMLS CUI [1])
Bone marrow transplantation; stem cell transplantation
Item
DID THE PATIENT RECEIVE A BONE MARROW OR STEM CELL- TRANSPLANT?
boolean
C1504389 (UMLS CUI [1])
Disease progression
Item
DID PATIENT PROGRESS WITHIN 12 MONTHS FOLLOWING THE ADJUVANT CHEMOTHERAPY?
boolean
C0242656 (UMLS CUI [1])
Total dose Doxorubicin
Item
WHAT WAS THE TOTAL DOSE OF DOXORUBICIN IN AN ADJUVANT SETTING?
float
C2986497 (UMLS CUI [1,1])
C0013089 (UMLS CUI [1,2])
C0014582 (UMLS CUI [1,3])
Total dose Epirubicin
Item
WHAT WAS THE TOTAL DOSE OF EPIRUBICIN USED IN AN ADJUVANT SETTING?
float
C2986497 (UMLS CUI [1,1])
C0014582 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial